JP2011006480A5 - - Google Patents

Download PDF

Info

Publication number
JP2011006480A5
JP2011006480A5 JP2010228356A JP2010228356A JP2011006480A5 JP 2011006480 A5 JP2011006480 A5 JP 2011006480A5 JP 2010228356 A JP2010228356 A JP 2010228356A JP 2010228356 A JP2010228356 A JP 2010228356A JP 2011006480 A5 JP2011006480 A5 JP 2011006480A5
Authority
JP
Japan
Prior art keywords
group
compound
cancer
lower alkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010228356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011006480A (ja
JP5679757B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011006480A publication Critical patent/JP2011006480A/ja
Publication of JP2011006480A5 publication Critical patent/JP2011006480A5/ja
Application granted granted Critical
Publication of JP5679757B2 publication Critical patent/JP5679757B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2010228356A 2002-11-07 2010-10-08 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法 Expired - Fee Related JP5679757B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42535202P 2002-11-07 2002-11-07
US60/425,352 2002-11-07
US47374303P 2003-05-27 2003-05-27
US60/473,743 2003-05-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005507102A Division JP4641941B2 (ja) 2002-11-07 2003-11-07 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013147528A Division JP2013213054A (ja) 2002-11-07 2013-07-16 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Publications (3)

Publication Number Publication Date
JP2011006480A JP2011006480A (ja) 2011-01-13
JP2011006480A5 true JP2011006480A5 (US20040106767A1-20040603-C00005.png) 2011-11-17
JP5679757B2 JP5679757B2 (ja) 2015-03-04

Family

ID=32314587

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2005507102A Expired - Fee Related JP4641941B2 (ja) 2002-11-07 2003-11-07 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法
JP2010228356A Expired - Fee Related JP5679757B2 (ja) 2002-11-07 2010-10-08 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法
JP2013147528A Pending JP2013213054A (ja) 2002-11-07 2013-07-16 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005507102A Expired - Fee Related JP4641941B2 (ja) 2002-11-07 2003-11-07 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013147528A Pending JP2013213054A (ja) 2002-11-07 2013-07-16 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Country Status (14)

Country Link
US (2) US20040152708A1 (US20040106767A1-20040603-C00005.png)
EP (3) EP2135867B1 (US20040106767A1-20040603-C00005.png)
JP (3) JP4641941B2 (US20040106767A1-20040603-C00005.png)
KR (2) KR100996996B1 (US20040106767A1-20040603-C00005.png)
AT (1) ATE452888T1 (US20040106767A1-20040603-C00005.png)
AU (1) AU2003291337B2 (US20040106767A1-20040603-C00005.png)
CA (1) CA2505368C (US20040106767A1-20040603-C00005.png)
CY (1) CY1110295T1 (US20040106767A1-20040603-C00005.png)
DE (1) DE60330703D1 (US20040106767A1-20040603-C00005.png)
DK (1) DK1562941T3 (US20040106767A1-20040603-C00005.png)
ES (2) ES2436296T3 (US20040106767A1-20040603-C00005.png)
PT (1) PT1562941E (US20040106767A1-20040603-C00005.png)
SI (1) SI1562941T1 (US20040106767A1-20040603-C00005.png)
WO (1) WO2004043954A2 (US20040106767A1-20040603-C00005.png)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69734362T2 (de) 1996-12-03 2006-07-20 Sloan-Kettering Institute For Cancer Research Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon
US8618085B2 (en) * 2000-04-28 2013-12-31 Koasn Biosciences Incorporated Therapeutic formulations of desoxyepothilones
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
SI1767535T1 (sl) 2002-08-23 2010-03-31 Sloan Kettering Inst Cancer Sinteza epotilonov njihovih intermediatov analogov in uporaba le teh
US7384964B2 (en) * 2002-08-23 2008-06-10 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
CN101088998A (zh) * 2002-11-07 2007-12-19 科桑生物科学公司 反式-9,10-脱氢埃坡霉素c和d,其类似物以及制备这些化合物的方法
US20040152708A1 (en) * 2002-11-07 2004-08-05 Yong Li Trans-9,10-dehydroepothilone C and D, analogs thereof and methods of making the same
CA2518872A1 (en) * 2003-03-28 2004-10-14 Kosan Biosciences, Inc. Devices, methods, and compositions to prevent restenosis
WO2005034964A1 (en) * 2003-10-09 2005-04-21 Kosan Biosciences, Inc. Therapeutic formulations
US20050215604A1 (en) * 2004-03-26 2005-09-29 Kosan Biosciences, Inc. Combination therapies with epothilones and carboplatin
US7981998B2 (en) * 2006-12-14 2011-07-19 Aileron Therapeutics, Inc. Bis-sulfhydryl macrocyclization systems
WO2008076904A1 (en) 2006-12-14 2008-06-26 Aileron Therapeutics, Inc. Bis-sulfhydryl macrocyclization systems
JP5649825B2 (ja) 2007-01-31 2015-01-07 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド 安定化させたp53ペプチドおよびその使用法
JP4997293B2 (ja) 2007-02-23 2012-08-08 エイルロン セラピューティクス,インコーポレイテッド トリアゾール大環状系
KR20160061439A (ko) 2007-03-28 2016-05-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
WO2008141234A2 (en) * 2007-05-11 2008-11-20 Kosan Biosciences Incorporated Methods of making epothilones
US8030503B2 (en) 2007-05-11 2011-10-04 Kosan Biosciences Incorporated Process for the preparation of epothilones
CN102256615A (zh) 2009-01-14 2011-11-23 爱勒让治疗公司 拟肽大环化合物
CA2774973A1 (en) 2009-09-22 2011-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
KR102104762B1 (ko) 2010-08-13 2020-04-24 에일러론 테라퓨틱스 인코포레이티드 펩티도미메틱 거대고리
KR20140100937A (ko) 2011-10-18 2014-08-18 에일러론 테라퓨틱스 인코포레이티드 펩티도미메틱 거대고리
CN104144695A (zh) 2012-02-15 2014-11-12 爱勒让治疗公司 三唑交联的和硫醚交联的拟肽大环化合物
CN107216380A (zh) 2012-02-15 2017-09-29 爱勒让治疗公司 拟肽大环化合物
CA2776178A1 (en) 2012-04-05 2013-10-05 Hydro-Quebec Ionic compounds
KR20150082307A (ko) 2012-11-01 2015-07-15 에일러론 테라퓨틱스 인코포레이티드 이치환 아미노산 및 이의 제조 및 사용 방법
BR112017005598A2 (pt) 2014-09-24 2017-12-12 Aileron Therapeutics Inc macrociclos peptidomiméticos e usos dos mesmos
SG10201902598VA (en) 2014-09-24 2019-04-29 Aileron Therapeutics Inc Peptidomimetic macrocycles and formulations thereof
EP3294318A4 (en) 2015-03-20 2019-04-03 Aileron Therapeutics, Inc. PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
US10059741B2 (en) 2015-07-01 2018-08-28 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
WO2017044633A1 (en) 2015-09-10 2017-03-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of mcl-1

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148223T3 (es) 1992-03-23 2000-10-16 Univ Georgetown Taxol encapsulado en liposomas y metodo para su uso.
AU6833994A (en) 1993-05-17 1994-12-12 Liposome Company, Inc., The Incorporation of taxol into liposomes and gels
US5415869A (en) 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5662883A (en) 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5534270A (en) 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
PL189698B1 (pl) 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
ES2324378T3 (es) 1998-02-05 2009-08-05 Novartis Ag Composicion farmaceutica que contiene epotilona.
US6596875B2 (en) * 2000-02-07 2003-07-22 James David White Method for synthesizing epothilones and epothilone analogs
DE19954229A1 (de) * 1999-11-04 2001-05-10 Schering Ag Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
DE19907480A1 (de) * 1999-02-11 2000-08-17 Schering Ag Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
US6156373A (en) 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
JP2003500368A (ja) 1999-05-24 2003-01-07 ソーナス ファーマシューティカルス,インコーポレイテッド 溶解度が不十分な薬剤のためのエマルジョンビヒクル
GB9918429D0 (en) 1999-08-04 1999-10-06 Novartis Ag Organic compounds
ATE309369T1 (de) 2000-04-28 2005-11-15 Kosan Biosciences Inc Heterologe herstellung von polyketiden
WO2001092255A2 (en) * 2000-05-26 2001-12-06 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
US6906188B2 (en) * 2001-04-30 2005-06-14 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Method for synthesizing epothilones and epothilone analogs
US20030176368A1 (en) * 2001-09-06 2003-09-18 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
US7649006B2 (en) * 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
SI1767535T1 (sl) * 2002-08-23 2010-03-31 Sloan Kettering Inst Cancer Sinteza epotilonov njihovih intermediatov analogov in uporaba le teh
US6921769B2 (en) * 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US20040152708A1 (en) * 2002-11-07 2004-08-05 Yong Li Trans-9,10-dehydroepothilone C and D, analogs thereof and methods of making the same

Similar Documents

Publication Publication Date Title
JP2011006480A5 (US20040106767A1-20040603-C00005.png)
JP2017533968A5 (US20040106767A1-20040603-C00005.png)
JP2013510120A5 (US20040106767A1-20040603-C00005.png)
JP2013513613A5 (US20040106767A1-20040603-C00005.png)
JP2013537203A5 (US20040106767A1-20040603-C00005.png)
JP2013508279A5 (US20040106767A1-20040603-C00005.png)
JP2017531038A5 (US20040106767A1-20040603-C00005.png)
JP2017537949A5 (US20040106767A1-20040603-C00005.png)
JP2014508804A5 (US20040106767A1-20040603-C00005.png)
JP2011526924A5 (US20040106767A1-20040603-C00005.png)
JP2011520906A5 (US20040106767A1-20040603-C00005.png)
JP2013532652A5 (US20040106767A1-20040603-C00005.png)
JP2012506872A5 (US20040106767A1-20040603-C00005.png)
JP2010525056A5 (US20040106767A1-20040603-C00005.png)
JP2010523522A5 (US20040106767A1-20040603-C00005.png)
JP2014518266A5 (US20040106767A1-20040603-C00005.png)
JP2007522142A5 (US20040106767A1-20040603-C00005.png)
JP2009507909A5 (US20040106767A1-20040603-C00005.png)
JP2006506443A5 (US20040106767A1-20040603-C00005.png)
JP2010518094A5 (US20040106767A1-20040603-C00005.png)
JP2014505107A5 (US20040106767A1-20040603-C00005.png)
JP2016040288A5 (US20040106767A1-20040603-C00005.png)
JP2011507896A5 (US20040106767A1-20040603-C00005.png)
JP2015508092A5 (US20040106767A1-20040603-C00005.png)
JP2013542261A5 (US20040106767A1-20040603-C00005.png)